Back

Prevalence of non pulmonary vein triggers and pulmonary pressure change in atrial fibrillation ablation for cardiac amyloidosis patients

9 April 2024 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 7 - ablation Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Vincenzo Mirco La Fazia

Texas cardiac Arrhythmia, Austin (United States of America)

7 More presentations in this session

Presentation thumbnail
J-curved phenomenon between the prevalence of left atrial low-voltage areas and body mass index existed in patients with atrial fibrillation ablation
Doctor Y. Matsuda (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Effects of diagnosis-to-ablation time and antiarrhythmic drug responsiveness on the rhythm outcomes of atrial fibrillation catheter ablation
Doctor H. Kim (Ulsan, KR)
Abstract Slides Video
Presentation thumbnail
Impact of age on atrial arrhythmia recurrence following cryoballoon pulmonary-vein isolation
Doctor A. Boehmer (Wiesbaden, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation cryoablation guided by pulmonary vein pressure: comparison with the standard strategy
Doctor S. Madero (Valladolid, ES)
Abstract Slides Video
Presentation thumbnail
Real-world multicenter registry on a novel focal lattice tip catheter toggling between pulsed electric field and radiofrequency for atrial tachyarrhythmia ablation
Doctor D. Della Rocca (Brussels, BE)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation: treatment 7 - ablation

The Event

Event poster

EHRA 2024

9 April 2024 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation recurrence rates in patients with transthyretin cardiac amyloidosis undergoing pulmonary vein isolation: a comparative retrospective study with propensity score matching
thumbnail
Congress Presentation
Reduced heart failure hospitalizations and improved quality of life in cardiac amyloidosis patients undergoing atrial fibrillation ablation
thumbnail
Congress Presentation
Trends in prevalence and clinical outcomes of patients with atrial fibrillation and cardiac amyloidosis- from a nationwide registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources